| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |